` PYPD (PolyPid Ltd) vs S&P 500 Comparison - Alpha Spread

PYPD
vs
S&P 500

Over the past 12 months, PYPD has underperformed S&P 500, delivering a return of -3% compared to the S&P 500's +15% growth.

Stocks Performance
PYPD vs S&P 500

Loading
PYPD
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
PYPD vs S&P 500

Loading
PYPD
S&P 500
Difference
www.alphaspread.com

Performance By Year
PYPD vs S&P 500

Loading
PYPD
S&P 500
Add Stock

Competitors Performance
PolyPid Ltd vs Peers

PolyPid Ltd
Glance View

Market Cap
35.2m USD
Industry
Pharmaceuticals

PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

PYPD Intrinsic Value
5.98 USD
Undervaluation 42%
Intrinsic Value
Price
Back to Top